The latest Battlefield 6 update is now live, and it's a doozy. Besides bringing the California Resistance additions of Season 1, the patch addresses some latent glitches and tweaks aim assist, though ...

GameSpot may get a commission from retail offers. Call of Duty: Black Ops 7 is finally here, and one of the main pieces of feedback from players thus far is around the game's aim-assist feature.

EA and Battlefield Studios have plans to tweak aim assist settings for Battlefield 6 controller users – but that hasn’t stopped PC players from digging into the files to turn off crossplay. Senior ...

If you're one of the Battlefield 6 players who've had problems with the aim assist, good news - it's getting toned down. A nerf is being deployed to make aiming easier, after consistent complaints the ...

GameSpot may get a commission from retail offers. Like many FPS games on console, Battlefield 6 will feature aim-assist--and the developer claims it will be "very light." That may make it feel ...

JERUSALEM, Sept 3 (Reuters) - Israeli cyber security firm Cato Networks said on Wednesday it was buying cyber startup Aim Security, its first ever acquisition, and raising another $50 million in a ...

The Navy and Air Force have requested approximately $1 billion for Fiscal Year 2026 to continue the development of the air-to-air munition. The classified munition has been in development since the ...

A new name in the laptop space, AIM, is 'AIM'-ing both high and low. That is, high in ambition, and low in price. You see, the company has announced plans to release a gaming laptop powered by AMD's ...

The AMD Ryzen AI Max+ 395 “Strix Halo” processor is a ridiculously powerful mobile chip that combines a 16-core, 32-thread CPU with a Radeon 8060S 40-core integrated GPU that offers the kind of ...

What if you could own a laptop that combines innovative performance with affordability, all while redefining what integrated graphics can achieve? Enter the AIM MAX Plus, a device powered by the ...

Biotechnology firms are increasingly turning to innovative combination therapies to tackle hard-to-treat cancers, with promising results sparking investor interest. AIM ImmunoTech Inc. (NYSE:AIM) is ...